Detalles de la búsqueda
1.
Treatment of influenza with neuraminidase inhibitors.
Curr Opin Infect Dis
; 31(6): 514-519, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30320639
2.
Antiviral treatment of severe non-influenza respiratory virus infection.
Curr Opin Infect Dis
; 30(6): 573-578, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29095723
3.
Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC).
BMC Infect Dis
; 17(1): 128, 2017 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28166743
4.
Molecular Point-of-care Testing for Influenza to Improve Early Neuraminidase Inhibitor Treatment and Outcomes in Hospitalized Adults.
Clin Infect Dis
; 68(12): 2154-2155, 2019 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30541020
5.
Emergency Department point-of-care antiviral host response testing is accurate during periods of multiple respiratory virus co-circulation.
J Infect
; 88(1): 41-47, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37977337
6.
Clinical Outcomes of Rapid Respiratory Virus Testing in Emergency Departments: A Systematic Review and Meta-Analysis.
JAMA Intern Med
; 184(5): 528-536, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436951
7.
Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial.
Eur Respir J
; 52(2)2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29946003
8.
Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial.
Lancet Infect Dis
; 23(8): 945-955, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37116527
9.
Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19.
J Infect
; 84(4): 558-565, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35108599
10.
FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department.
Infect Control Hosp Epidemiol
; 43(8): 979-986, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35094739
11.
Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study.
Infect Dis Ther
; 11(3): 1267-1280, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35534764
12.
A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries.
J Infect
; 84(1): 48-55, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606784
13.
Blood gene expression predicts intensive care unit admission in hospitalised patients with COVID-19.
Front Immunol
; 13: 988685, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203591
14.
Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19.
Front Immunol
; 13: 853265, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35663963
15.
Influenza vaccination: protecting the most vulnerable.
Eur Respir Rev
; 30(159)2021 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650528
16.
SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death.
J Infect
; 83(4): 458-466, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363885
17.
Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial.
Lancet Respir Med
; 9(4): 419-429, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285143
18.
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
Front Immunol
; 12: 694759, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34335606
19.
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Med
; 2(6): 701-719.e19, 2021 06 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34223402
20.
SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study.
J Infect
; 81(6): 966-972, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-33207254